Stents Farmacológicos para Todos: o Preço Vale a Pena? / Drug-Eluting Stents for Everyone: Is the Price Worth It?
Arq. bras. cardiol
;
115(1): 90-91, jul. 2020.
Article
in Portuguese
| LILACS, SES-SP
| ID: biblio-1131270
Subject(s)
Análise de Custo Benefício; Coronary Reestenosis; Cost-Benefit Analysis; Drug-Eluting Stents; Infarto do Miocárdio; Intervenção Coronária Percutânea; Myocardial Infarction; Percutaneous Coronary Intervention; Reestenose Coronária; Sistema Único de Saúde (SUS; Stents Farmacológicos; Unified Health System (SUS)
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Coronary Restenosis
/
Drug-Eluting Stents
/
Percutaneous Coronary Intervention
Type of study:
Health economic evaluation
Limits:
Humans
Country/Region as subject:
South America
/
Brazil
Language:
Portuguese
Journal:
Arq. bras. cardiol
Year:
2020
Type:
Article
Institution/Affiliation country:
Hospital Israelita Albert Einstein/BR
/
Universidade Federal de São Paulo/BR
Similar
MEDLINE
...
LILACS
LIS